Stephen W. Webster - Aug 2, 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role: Director
Signature: /s/ Robert Crotty, by power of attorney
Stock symbol: NBRV
Transactions as of: Aug 2, 2021
Transactions value $: -$932
Form type: 4
Date filed: 8/4/2021, 09:08 PM
Previous filing: Jul 30, 2021
Next filing: Mar 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NBRV	Ordinary Shares	Sale	-$932	-777	-3.88%	$1.20	19.3K	Aug 2, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.205, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.205, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.